US20060182695A1 - Peroxidase-activating oral compositions - Google Patents
Peroxidase-activating oral compositions Download PDFInfo
- Publication number
- US20060182695A1 US20060182695A1 US11/200,266 US20026605A US2006182695A1 US 20060182695 A1 US20060182695 A1 US 20060182695A1 US 20026605 A US20026605 A US 20026605A US 2006182695 A1 US2006182695 A1 US 2006182695A1
- Authority
- US
- United States
- Prior art keywords
- hydrogen peroxide
- solid
- finely divided
- peroxidase
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
Definitions
- This present invention relates to a method for activating a peroxidase enzyme system in situ.
- oxidizing agents include hypothiocyanite (OSCN-/HOSCN), hypochlorite (OC1- ⁇ HOC1), and hypoidite (OI- ⁇ HOI). These agents are known to inhibit glycolysis, penetrate prokaryotic cell walls, and generally disrupt a wide variety of processes crucial to the survival of lower organisms at concentrations greater or equal to about 100 micromoles per liter.
- the oxidizing agents are formed from the detoxification of hydrogen peroxide by mammalian peroxidase systems, such as those found in saliva, cervical fluid, lachrymal fluid and leukocytes. Examples of such peroxidase system enzymes are myeloperoxidase, lactoperoxidase, and salivary peroxidase.
- U.S. Pat. No. 4,269,822, U.S. Pat. No. 4,564,519 and U.S. Pat. No. 4,578,265 further describe dentifrice compositions containing an oxidoreductase enzyme and its specific substrate in an aqueous solution for the purpose of producing hydrogen peroxide or other antimicrobial oxidizing compounds such as hypothiocyanite ion.
- a more predictable amount of hydrogen peroxide (and subsequently hypothiocyanite ions) is produced by the compositions of Pellico et al., compared with those of the Hoogendorn references. The differences between the two compositions reflect the availability of glucose in the oral cavity as substrate for glucose oxidase.
- U.S. Pat. No. 4,564,519 describes a chewable dentifrice, such as a chewing gum or lozenge, which contains a dual enzyme system for producing hypothiocyanite ions upon being chewed or otherwise activated by the moisture in saliva.
- Such compositions suffer from similar drawbacks to those mentioned immediately above namely a slow rate of enzymatically-produced hydrogen peroxidase as well as a reliance on a cariogenic compound.
- compositions capable of producing hydrogen peroxide or other oxidizing agents upon activation with moisture are taught in U.S. Pat. No. 4,320,116, U.S. Pat. No. 4,726,948, and U.S. Pat. No. 4,929,466. These compositions are foodstuffs intended for consumption by livestock in order to limit the growth of harmful bacterial within the animal's gastrointestinal tract.
- These references describe the use of various enzymatic and non-enzymatic sources for hydrogen peroxide, where the enzymatic sources are glucose oxidase/glucose and the non-enzymatic sources are sodium perborate, sodium percarbonate, and calcium peroxide.
- compositions capable of rapidly producing antimicrobial hypohalite ions within the limited contact time available in most oral hygiene procedures.
- compositions capable of rapidly producing antimicrobial hypohalite ions upon contact with saliva within the limited contact time available in most oral hygiene procedures.
- a novel oral care composition is provided.
- a preferred embodiment of the invention is a non-enzymatic, water-soluble hydrogen peroxide precursor, capable of rapidly releasing an effective amount of hydrogen peroxide for activating the peroxidase system in the oral cavity, upon contact with an aqueous solution; and a pH adjusting agent capable of producing a selected pH in the aqueous solution for facilitating the rapid release of the hydrogen peroxide from the hydrogen peroxide precursor and the activation of the peroxidase enzyme in the oral cavity.
- a process for manufacturing an oral care product comprising the steps of obtaining an alkali metal percarbonate; dispersing the percarbonate in a non-hygroscopic material so as to encapsulate the percarbonate; obtaining particles of percarbonate encapsulated in the non-hygroscopic material; associating the percarbonate particles with a pH adjusting agent; and formulating the particles into an oral care product.
- a method for activating a peroxidase system in an oral cavity of an animal including the steps of selecting a non-enzymatic water soluble hydrogen peroxide precursor capable of rapidly releasing an effective amount of hydrogen peroxide for activating the peroxidase system in the oral cavity upon contact with an aqueous solution; mixing the precursor with a pH adjusting agent capable of producing a selected pH in the aqueous solution for facilitating the rapid release of the hydrogen peroxide from the hydrogen peroxide precursor and the activation of the peroxidase enzyme in the oral cavity; and administering to the oral cavity the precursor and pH-adjusting agent in a suitable formulation.
- the present invention relates to oral care compositions which upon contact with an aqueous solution, are capable of rapidly activating a peroxidase enzyme so as to release hydrogen peroxide.
- concentrations of the components of the oral composition are given in molar units which denote the concentration of the component in the aqueous contact solution.
- the limiting factor in all of the mammalian antimicrobial peroxidase systems is the availability of the substrate, namely hydrogen peroxide. Furthermore, the pH of the aqueous environment determines not only the effective release of hydrogen peroxide from the precursor but also the activity of the peroxidase system and the efficacy of the resulting oxidizing agents in penetrating the cell walls of microorganisms.
- non-ionized species of hypohalite ions more readily penetrates the cell walls of microorganisms then does the ionized species thereby having increased efficiency in inhibiting the metabolism of the microorganisms.
- the distribution of ionized versus non-ionized species is highly pH dependent.
- the pH activity profiles of the peroxidase enzymes lactoperoxidase, salivary peroxidase, and myeloperoxidase is maximum between pH 5 and 6, but drop off sharply below pH 4.0 and above pH 7.5.
- the pH of the medium surrounding the peroxidase enzymes must be within the range of about pH 4.0 to about pH 7.5. This pH range also favors the anti-microbial non-ionized hypohalite species which prevail at lower pH levels.
- compositions of the invention include a non-enzymatic water-soluble hydrogen peroxide precursor and a water-soluble pH adjusting component capable of providing a pH to an aqueous contact solution of between about 4.0 and 7.9
- the aqueous contact solution may commonly be saliva, but may also include an aqueous solution that is mixed with the precursor and pH adjusting agent prior to contact with the oral cavity.
- the non-enzymatic water-soluble precursor may be selected from the group of stable persalts including, but not limited to, alkali metal percarbonates, for example, sodium and potassium percarbonate, alkali metal perborates, alkali metal peroxides, and hydrogen peroxide complexes such as carbamide peroxide.
- alkali metal percarbonates for example, sodium and potassium percarbonate
- alkali metal perborates alkali metal peroxides
- hydrogen peroxide complexes such as carbamide peroxide.
- Preferred non-enzymatic hydrogen peroxide precursors are sodium percarbonate and carbamide peroxide due to their solubility characteristics and relatively benign toxicity in limited concentrations.
- the most preferred non-enzymatic hydrogen peroxide precursor is sodium percarbonate.
- Sodium percarbonate is a relatively stable complex containing 2 moles of sodium carbonate complexed with 3 moles of hydrogen peroxide (27% hydrogen peroxide by weight). It is highly water soluble (120 grams per liter at 20° C.) and produces a pH upon dissolution of between 10 and 11 (for a 1% solution).
- sodium percarbonate possesses the desirable hydrogen peroxide-releasing properties for the practice of the present invention, alone they are of little utility for the activation of a peroxidase enzyme due to their high in-solution pH properties. Accordingly, a pH adjusting agent has been utilized to normalize the pH to a range of 4.0-7.9.
- Carbamide peroxide is a 1 to 1 molar complex between urea and hydrogen peroxide (35% hydrogen peroxide by weight) with a molecular weight of 94.07. It is usually manufactured in the form of crystals which are highly soluble in water (800 grams per liter of water at 20° C. to yield a saturated solution of 44.4% carbamide peroxide, equivalent to a hydrogen peroxide concentration of 15.5%). However, when carbamide peroxide is solubilized in water, a pH of approximately 3.40 (for a saturated solution) to approximately 4.05 (for a 1% solution) is obtained. This pH is slightly below the desirable range, according to the invention, for activating a peroxidase enzyme in the aqueous contact solution absent a pH adjusting agent.
- the pH adjusting agent of the present invention may include any toxicologically acceptable and preferably water-soluble ingredient which is capable of producing an aqueous contact solution pH of between about 4.0 and about 7.5. Most preferably, the pH adjusting agent will provide a pH of between 5.0 and 6.0. Such pH adjusting agents include a wide variety of common buffers, acidulants, and/or alkalizers which are well known to those skilled in the art.
- Examples include organic acids and their alkali metal salts, such as citric acid, malic acid, butyric acid, gluconic acid, adipic acid, glutaric acid, and malonic acid; amines such as triethanolamine and tris(hydroxyaminomethane); alkali metal hydroxides, such as sodium hydroxide, potassium hydroxide, and ammonium hydroxide; and combinations thereof.
- these pH adjusting agents are free of water of hydration in order to achieve long-term stability in the presence of the hydrogen peroxide precursor.
- the optimum concentration of the pH-adjusting agent is the lowest level necessary to achieve the desired pH adjustment of the aqueous contact solution to between 4.0 and 7.5. This concentration of the pH adjusting agent is in the range of about 0.01% by weight of the composition to about 1% by weight of the composition. However, higher and lower amounts may have utility in circumstances where the buffering capacity of the surrounding medium is either very strong or very weak, respectively.
- the oral care composition described above generates hydrogen peroxide to be used as substrate for the peroxidase system in a manner that permits the concentration of hydrogen peroxide generated overall to be reduced while increasing the rate of its production.
- This provides a safe and effective antimicrobial composition.
- the prior art describes antimicrobial activity associated with oral care products containing or generating hydrogen peroxide
- the present invention provides for the first time the particular advantages of both limiting the concentration of hydrogen peroxide to a level which is suitable for the activation of a peroxidase enzyme (less than about 10 millimoles per liter in situ) and providing or limiting the pH range of the in situ composition/saliva fluids to that which is also most advantageous for activation of a peroxidase enzyme.
- the antimicrobial activity of the oral compositions depend on the presence of an oxygen acceptor.
- the preferred oxygen acceptor for oral care applications i.e., in the presence of salivary peroxidase or lactoperoxidase
- is the thiocyanate ion which can be provided to the composition through the inclusion of non-toxic levels of a thiocyanate salt, such as potassium or sodium thiocyanate.
- a thiocyanate salt such as potassium or sodium thiocyanate.
- the level of thiocyanate salt included in said compositions will be from about 1.0 millimolar to about 10.0 millimolar (again, as above, based upon the concentration achieved in the aqueous contact solution).
- the composition of the invention may be further enhanced by incorporating halide ions in the aqueous contact solution.
- One or more oxygen-accepting halide or pseudohalide ions may be incorporated in the aqueous contact solution. These ions may already be present in solution (such as thiocyanate ion, which is present in saliva), or alternatively they may be provided as auxiliary components in the inventive compositions.
- oral care product use results in a dilution of composition components on the order of 1 part composition to from about 1 part aqueous contact solution to about 5 parts aqueous contact solution (from about 1 to 1 to about 1 to 5). It is desirable that the non-enzymatic hydrogen peroxide precursors should be present at a level sufficient to release a minimum amount of hydrogen peroxide of approximately 100 micromoles per liter. A preferred range of hydrogen peroxide released is in the range of from about 500 micromoles per liter to about 2,000 micromoles per liter.
- the determination of the amounts of hydrogen peroxide that are released from a given composition in vitro are relatively simple to predict.
- peroxidase enzyme may typically be present in the aqueous contact solution (such as salivary peroxidase, which is present in saliva)
- additional peroxidase enzyme preferably lactoperoxidase
- lactoperoxidase may be included in the inventive compositions in a range of from about 10 ABTS (2,2′-Azinobis(3-ethylbenzthiazoline sulfonic acid) units per gram of composition to about 1,000 ABTS units per gram of composition [under the assay conditions described in Pruitt, et al., Analytical Biochemistry 191, pp. 278-286 (1990)].
- compositions may be non-aqueous, dry, or otherwise substantially water-free mixtures, which can be applied or deposited on or within an orally acceptable carrier, such as a chewing gum, dental floss, anhydrous dentifrice, or animal chew.
- an orally acceptable carrier such as a chewing gum, dental floss, anhydrous dentifrice, or animal chew.
- the hydrogen peroxide precursors of the invention may be processed with little or no loss of activity from moisture pick-up if, prior to being deposited onto or into an orally acceptable carrier, the alkali metal percarbonate is first dispersed in a non-hygroscopic fluid or solid in order to coat or encapsulate each particle of the percarbonate prior to being entered into a manufacturing process.
- Alkali metal percarbonates processed in this manner show very little degradation during processing cycles due to moisture absorption and/or temperature exposure.
- the inventive aspect of the present invention stems from the requirement that said coating must necessarily consist of a moisture-resistant fluid which has mobility and will form a fluid interface in contact with bulk moisture. Only through the formation of a thin interfacial layer in contact with bulk moisture will the intimately admixed alkali metal percarbonate and non-hygroscopic fluid release the alkali metal percarbonate (as hydrogen peroxide and an alkali metal carbonate) into the neighboring aqueous phase.
- Preferred non-hygroscopic fluids and solids are non-solvents for alkali metal percarbonates. These fluids are water-insoluble, yet low enough in viscosity to be readily dispersed into a thin film or interface in the presence of bulk moisture.
- Such non-hygroscopic liquids include, but are not limited to, mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons, and fluorosilicones.
- Preferred non-hygroscopic solids are also water insoluble and must be capable of being melt processed at a temperature suitable for maintaining the stability of the alkali metal percarbonate.
- Suitable non-hygroscopic solids include, but are not limited to, waxy solids such as mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons, fluorosilicones, stearic acid, glyceryl monostearate, paraffin wax, microcrystalline wax, and fatty alcohols.
- An example of an applicable melt process includes batch melt processing, whereby the non-hygroscopic solid carrier is simply melted in bulk, whereupon the alkali metal percarbonate is added and dispersed.
- Another example of an applicable melt process is the fluid-bed processing technique described in U.S. Pat. No. 4,421,669, whereby the alkali metal percarbonate (in the form of a powdered or granular particle) is floated on an airstream and subsequently sprayed with melted droplets of the non-hygroscopic solid carrier.
- Both non-hygroscopic fluid and solid carriers may also include the pH-adjusting agents of the present invention, so as to simplify the application of both inventive components (i.e., the hydrogen peroxide precursor and the pH-adjusting agent) onto or into the oral care product delivery system.
- the hydrogen peroxide precursor and the pH-adjusting agent may be dispersed separately within two different non-hygroscopic carriers and subsequently applied onto or into the oral care product delivery system in a stepwise fashion.
- non-hygroscopic fluid or solid carrier for the alkali metal percarbonate is dependent upon the final oral care product delivery system contemplated.
- the percarbonate may be dispersed in a non-hygroscopic fluid carrier before being deposited on the surface of the chew.
- the alkali metal percarbonate may be dispersed in either a non-hygroscopic liquid or solid, to be subsequently added batchwise to the gum base and thence kneaded to achieve homogeneity.
- the finished chewing gum may be coated with a layer of either a liquid or solid dispersion of alkali metal percarbonate.
- the components of 8 compositions were added to a laboratory powder blender and mixed for 1 hour in order to assure complete mixing.
- the resulting white powders were extremely fine and free flowing.
- Fresh, whole unstimulated human saliva was collected from 3 subjects drooling into chilled plastic cups, said cups being placed in ice during and after the expectoration procedure, and the 3 samples of saliva pooled.
- a sample of the freshly-pooled saliva was warmed to 37° C. and evaluated for its hypothiocyanite ion concentration [recorded as OSCN (initial)] by the method of Mansson-Rahentulla, et al., Archives of Oral Biology 31, 10, pp. 661-668 (1986). Readings recorded as AOSCN@ are intended to reflect the combined concentration of OSCN-ion and the non-ionized HOSCN species.
- the powdered compositions of Table 1 which result in a solution pH of from about 3.82 to 7.95 are capable of rapidly elevating the concentration of hypothiocyanite ions in pooled, unstimulated whole human saliva.
- Supplementation of the mannitol in Table 1 with potassium thiocyanate (at a level capable of providing a 1.0 millimolar concentration of thiocyanate ion in the pooled saliva sample) resulted in an even more dramatic increase in the observed hypothiocyanite ion concentration, probably due to the reaction-limiting concentration of naturally occurring thiocyanate in the pooled saliva sample.
- Sample 1D The composition of Sample 1D was combined, in different proportions, with pooled saliva in order to produce pH-adjusted saliva containing varying concentrations of hydrogen peroxide [recorded as H 2 O 2 (actual)]. The theoretical concentration of hydrogen peroxide is also shown [recorded as H 2 O 2 (theoretical)]. The concentrations of OSCN produced are also recorded in Table 3 below.
- sample 1D was applied to the surface of 3.0 gram sticks of chewing gum at a coating rate of 0.05% by weight of gum in order to produce chewing gum which was capable of generating hydrogen peroxide upon contact with saliva, in addition to providing for a salivary pH adjustment to about 6.0.
- Sample 1D-coated chewing gum (3.05 grams) was broken into small pieces and vortexed with 3.05 grams of distilled water for 15 seconds. At exactly the 15 second point, a sample of the resulting fluid was assayed for hydrogen peroxide and pH as in Example I. The fluid contained a hydrogen peroxide concentration of 360 micromolar and the fluid pH was 6.03.
- a rawhide animal chew was prepared by talking 10 pounds of dried, unbasted rawhide chews, approximately 2 inches wide by 6 inches in length, and spray coating them at a 1.0 percent coating rate with the following composition; TABLE 5 COMPONENT AMOUNT Light Mineral Oil USP 87 grams Sodium Percarbonate (Solvay - FB 100) 10 grams Malic Acid (Powder FCC) 3 grams TOTAL 100 grams
- the above components were slurried until a fine dispersion of solids was obtained. Agitation continued during the spray process to prevent the settling out of the solids.
- the sprayed rawhide chews were dried at room temperature for 24 hours, during which time the initial surface gloss observed on the freshly sprayed chews disappeared.
- the Achew fluid@ contained a hydrogen peroxide concentration of 6.53 millimolar at a pH of 5.84 at 25° C.
- the Carbopol 980 NF was dispersed under high shear in the Glycerine 99.7% USP and subsequently deaerated.
- the Carbamide Peroxide was then dissolved in this mixture under low shear mixing.
- the Tris(hydroxymethyl)aminomethane was dissolved in the Distilled Water, and this phase dispersed into the main phase under 28 @ Hg vacuum in order to avoid entrapment of air.
- the resulting gel was highly viscous and transparent.
- the tris(hydroxymethyl)aminomethane USP serves as both a neutralizer for thickening the acidic carboxypolymethylene (Carbopol 98O NF) and as an alkalizer to provide a suitable peroxidase-active pH during the use of this product.
- the pH of a 1:5 dilution (1 part Example V to 5 parts Distilled Water) is 5.4, and the dilution showed a hydrogen peroxide concentration of 969 micromoles per liter.
Abstract
A peroxidase-activating oral care composition, in accordance with an embodiment of the invention, includes a non-enzymatic, water-soluble hydrogen peroxide precursor and a pH-adjusting agent capable of producing a selected pH in an aqueous solution. The composition facilitates the rapid release of hydrogen peroxide and results in the activation of a peroxidase enzyme in an oral cavity. A process for manufacturing the oral care composition including obtaining the precursor, dispersing it in a non-hygroscopic material so as to coat or encapsulate it, obtaining and associating the coated or encapsulated particles with a pH-adjusting agent, and formulating the particles into an oral care composition is provided in another embodiment. In addition, a method for activating a peroxidase system in an oral cavity of an animal, including selecting a non-enzymatic water soluble hydrogen peroxide precursor, mixing the precursor with a pH-adjusting agent, and administering the precursor and pH-adjusting agent in a suitable formulation to the oral cavity, is provided in a further embodiment of the invention.
Description
- This application is a continuation of co-pending U.S. patent application Ser. No. 10/456,205 filed on Jun. 6, 2003, which is a continuation of U.S. patent application Ser. No. 09/237,191 filed on Jan. 26, 1999 (U.S. Pat. No. 6,576,227), which is a continuation of U.S. patent application Ser. No. 08/698,474 filed on Aug. 15, 1996 (U.S. Pat. No. 5,908,614), and which claims benefit to U.S. Provisional Patent Application Ser. No. 60/012,537 filed on Feb. 29, 1996 and U.S. Provisional Patent Application Ser. No. 60/002,361 filed on Aug. 15, 1995, all of which are hereby incorporated by reference herein.
- This present invention relates to a method for activating a peroxidase enzyme system in situ.
- A number of naturally occurring antimicrobial systems rely upon the ability of certain oxidizing agents to disrupt metabolic processes of bacteria, fungi and viruses. Examples of such oxidizing agents include hypothiocyanite (OSCN-/HOSCN), hypochlorite (OC1-\HOC1), and hypoidite (OI-\HOI). These agents are known to inhibit glycolysis, penetrate prokaryotic cell walls, and generally disrupt a wide variety of processes crucial to the survival of lower organisms at concentrations greater or equal to about 100 micromoles per liter. The oxidizing agents are formed from the detoxification of hydrogen peroxide by mammalian peroxidase systems, such as those found in saliva, cervical fluid, lachrymal fluid and leukocytes. Examples of such peroxidase system enzymes are myeloperoxidase, lactoperoxidase, and salivary peroxidase.
- Attempts to exploit these natural antimicrobial systems have been directed to both the oral care field and the gastrointestinal tract. U.S. Pat. No. 4,150,113 and U.S. Pat. No. 4,178,362 (Hoogendorn, et al.) describe dentifrice compositions containing glucose oxidase that react with plaque and salivary glucose to produce low levels of hydrogen peroxide. Hydrogen peroxide production by such systems is, however, highly irregular due to the non-uniform distribution and unpredictable availability of substrate, namely glucose, in the oral cavity.
- U.S. Pat. No. 4,269,822, U.S. Pat. No. 4,564,519 and U.S. Pat. No. 4,578,265 (Pellico, et al.) further describe dentifrice compositions containing an oxidoreductase enzyme and its specific substrate in an aqueous solution for the purpose of producing hydrogen peroxide or other antimicrobial oxidizing compounds such as hypothiocyanite ion. A more predictable amount of hydrogen peroxide (and subsequently hypothiocyanite ions) is produced by the compositions of Pellico et al., compared with those of the Hoogendorn references. The differences between the two compositions reflect the availability of glucose in the oral cavity as substrate for glucose oxidase.
- There are, however, a number of disadvantages associated with the compositions of Pellico et al. These include: the limited rate of enzymatically-produced hydrogen peroxide that in turn produces the hypothiocyanite ion. The short duration of oral contact time, namely during toothbrushing, means that insufficient amounts of hypothiocyanite is available to effectively eliminate microbes in the oral cavity. In addition, the references utilize glucose oxidase as the oxidoreductase enzyme that in turn relies upon the availability of a sufficient concentration of glucose in solution to produce hydrogen peroxide. However, the glucose itself is a microbial substrate and is potentially cariogenic when present in an oral care product
- U.S. Pat. No. 4,564,519 describes a chewable dentifrice, such as a chewing gum or lozenge, which contains a dual enzyme system for producing hypothiocyanite ions upon being chewed or otherwise activated by the moisture in saliva. Such compositions suffer from similar drawbacks to those mentioned immediately above namely a slow rate of enzymatically-produced hydrogen peroxidase as well as a reliance on a cariogenic compound.
- Other solid or chewable compositions capable of producing hydrogen peroxide or other oxidizing agents upon activation with moisture are taught in U.S. Pat. No. 4,320,116, U.S. Pat. No. 4,726,948, and U.S. Pat. No. 4,929,466. These compositions are foodstuffs intended for consumption by livestock in order to limit the growth of harmful bacterial within the animal's gastrointestinal tract. These references describe the use of various enzymatic and non-enzymatic sources for hydrogen peroxide, where the enzymatic sources are glucose oxidase/glucose and the non-enzymatic sources are sodium perborate, sodium percarbonate, and calcium peroxide. However, it is known that sodium percarbonate and potassium percarbonate have extremely alkaline pH and are thus of little use in activating the peroxidase enzymes until exposed to the acidic environment within the gastrointestinal tract. Thus, the foodstuff compositions described in the reference cannot be used as a therapeutic or otherwise peroxidase-activating effect in the oral cavity.
- It would thus be advantageous to provide substantially non-cariogenic compositions capable of rapidly producing hydrogen peroxide in conditions that are suitable for peroxidase enzyme activation in the oral cavity.
- It would also be advantageous to provide compositions capable of rapidly producing antimicrobial hypohalite ions within the limited contact time available in most oral hygiene procedures.
- It would also be advantageous to provide compositions capable of rapidly producing antimicrobial hypohalite ions upon contact with saliva within the limited contact time available in most oral hygiene procedures.
- This invention satisfies the above needs. A novel oral care composition is provided.
- A preferred embodiment of the invention is a non-enzymatic, water-soluble hydrogen peroxide precursor, capable of rapidly releasing an effective amount of hydrogen peroxide for activating the peroxidase system in the oral cavity, upon contact with an aqueous solution; and a pH adjusting agent capable of producing a selected pH in the aqueous solution for facilitating the rapid release of the hydrogen peroxide from the hydrogen peroxide precursor and the activation of the peroxidase enzyme in the oral cavity.
- In a further embodiment of the invention, a process is provided for manufacturing an oral care product, comprising the steps of obtaining an alkali metal percarbonate; dispersing the percarbonate in a non-hygroscopic material so as to encapsulate the percarbonate; obtaining particles of percarbonate encapsulated in the non-hygroscopic material; associating the percarbonate particles with a pH adjusting agent; and formulating the particles into an oral care product.
- In a further embodiment of the invention, a method is provided for activating a peroxidase system in an oral cavity of an animal, including the steps of selecting a non-enzymatic water soluble hydrogen peroxide precursor capable of rapidly releasing an effective amount of hydrogen peroxide for activating the peroxidase system in the oral cavity upon contact with an aqueous solution; mixing the precursor with a pH adjusting agent capable of producing a selected pH in the aqueous solution for facilitating the rapid release of the hydrogen peroxide from the hydrogen peroxide precursor and the activation of the peroxidase enzyme in the oral cavity; and administering to the oral cavity the precursor and pH-adjusting agent in a suitable formulation.
- The present invention relates to oral care compositions which upon contact with an aqueous solution, are capable of rapidly activating a peroxidase enzyme so as to release hydrogen peroxide.
- The concentrations of the components of the oral composition are given in molar units which denote the concentration of the component in the aqueous contact solution.
- The limiting factor in all of the mammalian antimicrobial peroxidase systems is the availability of the substrate, namely hydrogen peroxide. Furthermore, the pH of the aqueous environment determines not only the effective release of hydrogen peroxide from the precursor but also the activity of the peroxidase system and the efficacy of the resulting oxidizing agents in penetrating the cell walls of microorganisms.
- It is known, for example, that the non-ionized species of hypohalite ions more readily penetrates the cell walls of microorganisms then does the ionized species thereby having increased efficiency in inhibiting the metabolism of the microorganisms. The distribution of ionized versus non-ionized species (for instance HOC1, or hypochlorous acid, versus OCl—, or hypochlorite ion) is highly pH dependent.
- The pH activity profiles of the peroxidase enzymes lactoperoxidase, salivary peroxidase, and myeloperoxidase is maximum between pH 5 and 6, but drop off sharply below pH 4.0 and above pH 7.5. Thus, in order to maintain peroxidatic function, it is here concluded that the pH of the medium surrounding the peroxidase enzymes must be within the range of about pH 4.0 to about pH 7.5. This pH range also favors the anti-microbial non-ionized hypohalite species which prevail at lower pH levels.
- Consequently, the compositions of the invention include a non-enzymatic water-soluble hydrogen peroxide precursor and a water-soluble pH adjusting component capable of providing a pH to an aqueous contact solution of between about 4.0 and 7.9 The aqueous contact solution may commonly be saliva, but may also include an aqueous solution that is mixed with the precursor and pH adjusting agent prior to contact with the oral cavity.
- The non-enzymatic water-soluble precursor may be selected from the group of stable persalts including, but not limited to, alkali metal percarbonates, for example, sodium and potassium percarbonate, alkali metal perborates, alkali metal peroxides, and hydrogen peroxide complexes such as carbamide peroxide. Preferred non-enzymatic hydrogen peroxide precursors are sodium percarbonate and carbamide peroxide due to their solubility characteristics and relatively benign toxicity in limited concentrations. The most preferred non-enzymatic hydrogen peroxide precursor is sodium percarbonate.
- Sodium percarbonate is a relatively stable complex containing 2 moles of sodium carbonate complexed with 3 moles of hydrogen peroxide (27% hydrogen peroxide by weight). It is highly water soluble (120 grams per liter at 20° C.) and produces a pH upon dissolution of between 10 and 11 (for a 1% solution). Thus, although sodium percarbonate possesses the desirable hydrogen peroxide-releasing properties for the practice of the present invention, alone they are of little utility for the activation of a peroxidase enzyme due to their high in-solution pH properties. Accordingly, a pH adjusting agent has been utilized to normalize the pH to a range of 4.0-7.9.
- Carbamide peroxide is a 1 to 1 molar complex between urea and hydrogen peroxide (35% hydrogen peroxide by weight) with a molecular weight of 94.07. It is usually manufactured in the form of crystals which are highly soluble in water (800 grams per liter of water at 20° C. to yield a saturated solution of 44.4% carbamide peroxide, equivalent to a hydrogen peroxide concentration of 15.5%). However, when carbamide peroxide is solubilized in water, a pH of approximately 3.40 (for a saturated solution) to approximately 4.05 (for a 1% solution) is obtained. This pH is slightly below the desirable range, according to the invention, for activating a peroxidase enzyme in the aqueous contact solution absent a pH adjusting agent.
- The pH adjusting agent of the present invention may include any toxicologically acceptable and preferably water-soluble ingredient which is capable of producing an aqueous contact solution pH of between about 4.0 and about 7.5. Most preferably, the pH adjusting agent will provide a pH of between 5.0 and 6.0. Such pH adjusting agents include a wide variety of common buffers, acidulants, and/or alkalizers which are well known to those skilled in the art. Examples include organic acids and their alkali metal salts, such as citric acid, malic acid, butyric acid, gluconic acid, adipic acid, glutaric acid, and malonic acid; amines such as triethanolamine and tris(hydroxyaminomethane); alkali metal hydroxides, such as sodium hydroxide, potassium hydroxide, and ammonium hydroxide; and combinations thereof. Preferably, these pH adjusting agents are free of water of hydration in order to achieve long-term stability in the presence of the hydrogen peroxide precursor. The optimum concentration of the pH-adjusting agent is the lowest level necessary to achieve the desired pH adjustment of the aqueous contact solution to between 4.0 and 7.5. This concentration of the pH adjusting agent is in the range of about 0.01% by weight of the composition to about 1% by weight of the composition. However, higher and lower amounts may have utility in circumstances where the buffering capacity of the surrounding medium is either very strong or very weak, respectively.
- The oral care composition described above generates hydrogen peroxide to be used as substrate for the peroxidase system in a manner that permits the concentration of hydrogen peroxide generated overall to be reduced while increasing the rate of its production. This provides a safe and effective antimicrobial composition. While the prior art describes antimicrobial activity associated with oral care products containing or generating hydrogen peroxide, the present invention provides for the first time the particular advantages of both limiting the concentration of hydrogen peroxide to a level which is suitable for the activation of a peroxidase enzyme (less than about 10 millimoles per liter in situ) and providing or limiting the pH range of the in situ composition/saliva fluids to that which is also most advantageous for activation of a peroxidase enzyme.
- The antimicrobial activity of the oral compositions depend on the presence of an oxygen acceptor. The preferred oxygen acceptor for oral care applications (i.e., in the presence of salivary peroxidase or lactoperoxidase) is the thiocyanate ion, which can be provided to the composition through the inclusion of non-toxic levels of a thiocyanate salt, such as potassium or sodium thiocyanate. In general, the level of thiocyanate salt included in said compositions will be from about 1.0 millimolar to about 10.0 millimolar (again, as above, based upon the concentration achieved in the aqueous contact solution). However, the composition of the invention may be further enhanced by incorporating halide ions in the aqueous contact solution. One or more oxygen-accepting halide or pseudohalide ions, including any of chloride, iodide, bromide, and thiocyanate and combinations thereof, may be incorporated in the aqueous contact solution. These ions may already be present in solution (such as thiocyanate ion, which is present in saliva), or alternatively they may be provided as auxiliary components in the inventive compositions.
- In general, oral care product use results in a dilution of composition components on the order of 1 part composition to from about 1 part aqueous contact solution to about 5 parts aqueous contact solution (from about 1 to 1 to about 1 to 5). It is desirable that the non-enzymatic hydrogen peroxide precursors should be present at a level sufficient to release a minimum amount of hydrogen peroxide of approximately 100 micromoles per liter. A preferred range of hydrogen peroxide released is in the range of from about 500 micromoles per liter to about 2,000 micromoles per liter. The determination of the amounts of hydrogen peroxide that are released from a given composition in vitro (for instance, under controlled conditions in contact with distilled water as a diluent) are relatively simple to predict. However, the determination of amounts of hydrogen peroxide released in vivo indicates that in vivo levels are well below those predicted in vitro. This difference may result from the destruction of hydrogen peroxide by salivary catalase, interaction of hydrogen peroxide with various organic matter and non-enzymatic reducing agents in saliva, and the destructive effect of dissolved metal ions in saliva. Thus, while an upper limit of 2.0 millimoles of hydrogen peroxide per liter is predictive of an in vitro effectiveness, concentrations as high as 30 millimoles per liter may be desirable to produce much lower observed in vivo concentrations of hydrogen peroxide.
- It should also be noted that an accumulation of high concentrations of hydrogen peroxide (greater than about 0.1 percent, or about 29 millimoles per liter) are not desirable due to the evidence that hydrogen peroxide is mutagenic and can cause cellular DNA damage at elevated concentrations. The prior art describes broad concentration ranges of hydrogen peroxide as having utility in oral hygiene and tooth whitening applications, but makes little reference to the potential harmful effects of hydrogen peroxide at concentrations, for instance, in the range of 1.5 to 3.0 percent by weight (441 to 882 millimolar).
- Although the peroxidase enzyme may typically be present in the aqueous contact solution (such as salivary peroxidase, which is present in saliva), additional peroxidase enzyme, preferably lactoperoxidase, may be included in the inventive compositions in a range of from about 10 ABTS (2,2′-Azinobis(3-ethylbenzthiazoline sulfonic acid) units per gram of composition to about 1,000 ABTS units per gram of composition [under the assay conditions described in Pruitt, et al., Analytical Biochemistry 191, pp. 278-286 (1990)].
- In a preferred embodiment of the invention, compositions may be non-aqueous, dry, or otherwise substantially water-free mixtures, which can be applied or deposited on or within an orally acceptable carrier, such as a chewing gum, dental floss, anhydrous dentifrice, or animal chew. These compositions, once dissolved in the aqueous solution at a selected pH, are capable of producing, in the absence of additional enzyme preparations, hydrogen peroxide that results in the rapid activation of an antimicrobial peroxidase enzyme system in vivo.
- The hydrogen peroxide precursors of the invention, such as the alkali metal percarbonates, may be processed with little or no loss of activity from moisture pick-up if, prior to being deposited onto or into an orally acceptable carrier, the alkali metal percarbonate is first dispersed in a non-hygroscopic fluid or solid in order to coat or encapsulate each particle of the percarbonate prior to being entered into a manufacturing process. Alkali metal percarbonates processed in this manner show very little degradation during processing cycles due to moisture absorption and/or temperature exposure. Although the concept of coating moisture-sensitive materials with water-insoluble or non-hygroscopic outer layers is not new to the art, the inventive aspect of the present invention stems from the requirement that said coating must necessarily consist of a moisture-resistant fluid which has mobility and will form a fluid interface in contact with bulk moisture. Only through the formation of a thin interfacial layer in contact with bulk moisture will the intimately admixed alkali metal percarbonate and non-hygroscopic fluid release the alkali metal percarbonate (as hydrogen peroxide and an alkali metal carbonate) into the neighboring aqueous phase.
- Preferred non-hygroscopic fluids and solids are non-solvents for alkali metal percarbonates. These fluids are water-insoluble, yet low enough in viscosity to be readily dispersed into a thin film or interface in the presence of bulk moisture. Such non-hygroscopic liquids include, but are not limited to, mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons, and fluorosilicones. Preferred non-hygroscopic solids are also water insoluble and must be capable of being melt processed at a temperature suitable for maintaining the stability of the alkali metal percarbonate. Suitable non-hygroscopic solids include, but are not limited to, waxy solids such as mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons, fluorosilicones, stearic acid, glyceryl monostearate, paraffin wax, microcrystalline wax, and fatty alcohols. An example of an applicable melt process includes batch melt processing, whereby the non-hygroscopic solid carrier is simply melted in bulk, whereupon the alkali metal percarbonate is added and dispersed. Another example of an applicable melt process is the fluid-bed processing technique described in U.S. Pat. No. 4,421,669, whereby the alkali metal percarbonate (in the form of a powdered or granular particle) is floated on an airstream and subsequently sprayed with melted droplets of the non-hygroscopic solid carrier.
- Both non-hygroscopic fluid and solid carriers may also include the pH-adjusting agents of the present invention, so as to simplify the application of both inventive components (i.e., the hydrogen peroxide precursor and the pH-adjusting agent) onto or into the oral care product delivery system. Alternatively, the hydrogen peroxide precursor and the pH-adjusting agent may be dispersed separately within two different non-hygroscopic carriers and subsequently applied onto or into the oral care product delivery system in a stepwise fashion.
- The choice of non-hygroscopic fluid or solid carrier for the alkali metal percarbonate is dependent upon the final oral care product delivery system contemplated. Where the formulation is an animal chew, such as a rawhide animal chew, the percarbonate may be dispersed in a non-hygroscopic fluid carrier before being deposited on the surface of the chew. Where the formulation is a chewing gum, the alkali metal percarbonate may be dispersed in either a non-hygroscopic liquid or solid, to be subsequently added batchwise to the gum base and thence kneaded to achieve homogeneity. Alternatively, the finished chewing gum may be coated with a layer of either a liquid or solid dispersion of alkali metal percarbonate.
- The following examples serve to illustrate a number of the inventive compositions, but are by no means intended to limit the scope of the overall invention.
- The components of 8 compositions were added to a laboratory powder blender and mixed for 1 hour in order to assure complete mixing. The resulting white powders were extremely fine and free flowing.
- Each sample 1A-1H (100 mg) was contacted with 100 ml distilled water at 25° C. and the resulting hydrogen peroxide concentration after 15 seconds [recorded as H2O2 (t=15 sec)] was determined by the method of Mottola, et al., Analytical Chemistry 42, pp. 410-411 (1970). The pH at 25° C. of each solution [recorded as pH (t=15 sec)] at the 15 second point was also determined. The results are recorded in Table 2 below.
TABLE 1 A comparison of 8 compositions (wt in gms) Component A B C D E F G H Mannitol 90 87 86 85.5 85 80 70 60 (Powder, USP) Sodium Percar- 10 10 10 10 10 10 10 10 bonate Powder Citric Acid — 3 4 4.5 5 10 20 30 (Powder, USP) Total 100 100 100 100 100 100 100 100 - Fresh, whole unstimulated human saliva was collected from 3 subjects drooling into chilled plastic cups, said cups being placed in ice during and after the expectoration procedure, and the 3 samples of saliva pooled. A sample of the freshly-pooled saliva was warmed to 37° C. and evaluated for its hypothiocyanite ion concentration [recorded as OSCN (initial)] by the method of Mansson-Rahentulla, et al., Archives of Oral Biology 31, 10, pp. 661-668 (1986). Readings recorded as AOSCN@ are intended to reflect the combined concentration of OSCN-ion and the non-ionized HOSCN species. The powdered compositions of the present example were then contacted with the pooled saliva at a concentration of 1.0 mg of powder in 1.0 ml of saliva. After 15 seconds, the saliva was reevaluated for its hypothiocyanite ion concentration as above [recorded as OSCN (t=15 sec)] and the results recorded in Table 2 below.
TABLE 2 hypothicyanite concentrations in saliva SAMPLE 1A 1B 1C 1D 1E 1F 1G H2O2 (t = 15 sec) in 750 765 760 755 760 760 765 micromoles/liter pH (t = 15 sec) @ 9.17 7.95 7.20 6.10 4.89 3.82 3.10 37 degrees C. OSCN (initial) in 42 42 42 42 42 42 42 micromoles/liter OSCN (t = 15 sec) in 19 114 160 269 257 199 58 micromoles/liter - It can been seen from the above that the powdered compositions of Table 1 which result in a solution pH of from about 3.82 to 7.95 are capable of rapidly elevating the concentration of hypothiocyanite ions in pooled, unstimulated whole human saliva. Supplementation of the mannitol in Table 1 with potassium thiocyanate (at a level capable of providing a 1.0 millimolar concentration of thiocyanate ion in the pooled saliva sample) resulted in an even more dramatic increase in the observed hypothiocyanite ion concentration, probably due to the reaction-limiting concentration of naturally occurring thiocyanate in the pooled saliva sample.
- The composition of Sample 1D was combined, in different proportions, with pooled saliva in order to produce pH-adjusted saliva containing varying concentrations of hydrogen peroxide [recorded as H2O2 (actual)]. The theoretical concentration of hydrogen peroxide is also shown [recorded as H2O2 (theoretical)]. The concentrations of OSCN produced are also recorded in Table 3 below. All measurements were made at t=15 seconds after mixing the prescribed weight of Sample 1D with saliva
TABLE 3 OSCN OSCN H2O2 (theoretical) H2O2 (actual) (MICROMOLES/ (MICROMOLES/ EXAMPLE 1D (MICROMOLES/ (MICROMOLES/ LITER) NO ADDED LITER) SCN @ 1 (MG/LITER) LITER) LITER) pH SCN MILLIMOLAR 10 7.94 <1 5.86 38 42 100 79.4 <1 6.02 88 87 1,000 794 52 6.10 285 420 2,000 1,588 120 6.18 321 598 4,000 3,176 2,185 6.20 339 712 6,000 4,764 3,890 6.25 301 690 10,000 7,941 6,920 6.25 233 662 20,000 15,882 13,202 6.26 110 272 40,000 31,764 29,990 6.25 93 160 100,000 79,410 78,540 6.25 37 90 - The composition of sample 1D was applied to the surface of 3.0 gram sticks of chewing gum at a coating rate of 0.05% by weight of gum in order to produce chewing gum which was capable of generating hydrogen peroxide upon contact with saliva, in addition to providing for a salivary pH adjustment to about 6.0.
- One stick of Sample 1D-coated chewing gum (3.05 grams) was broken into small pieces and vortexed with 3.05 grams of distilled water for 15 seconds. At exactly the 15 second point, a sample of the resulting fluid was assayed for hydrogen peroxide and pH as in Example I. The fluid contained a hydrogen peroxide concentration of 360 micromolar and the fluid pH was 6.03.
- Saliva samples from five subjects, ages 25-45, were collected as above, but rather than being pooled, were assayed individually for hypothiocyanite ion concentrations. The results are recorded below. The same volunteers were then asked to chew the coated chewing gum samples for a period of 2 minutes. Their saliva was collected again, and their salivary hypothiocyanite ion levels recorded. (Table 4). The results show a remarkable ability of the inventive composition to impart salivary peroxidase-activating properties to the chewing gum.
TABLE 4 SUBJECT OSCN BEFORE OSCN AFTER 1 29 micromolar 214 micromolar 2 56 micromolar 198 micromolar 3 45 micromolar 260 micromolar 4 39 micromolar 252 micromolar 5 28 micromolar 208 micromolar - A rawhide animal chew was prepared by talking 10 pounds of dried, unbasted rawhide chews, approximately 2 inches wide by 6 inches in length, and spray coating them at a 1.0 percent coating rate with the following composition;
TABLE 5 COMPONENT AMOUNT Light Mineral Oil USP 87 grams Sodium Percarbonate (Solvay - FB 100) 10 grams Malic Acid (Powder FCC) 3 grams TOTAL 100 grams - The above components were slurried until a fine dispersion of solids was obtained. Agitation continued during the spray process to prevent the settling out of the solids. The sprayed rawhide chews were dried at room temperature for 24 hours, during which time the initial surface gloss observed on the freshly sprayed chews disappeared.
- In order to determine the ability of the spray-coated rawhide chew to generate pH-adjusted hydrogen peroxide upon contact with water, single chews cut into four pieces and weighed. An equivalent amount of distilled water was weighed out and the coated chews vortexed in the water for 15 seconds. The Achew fluid@ contained a hydrogen peroxide concentration of 6.53 millimolar at a pH of 5.84 at 25° C.
- An anhydrous carbamide peroxide gel composition was prepared in order to demonstrate another option for delivery of the composition to the oral cavity.
TABLE 6 COMPONENT AMOUNT Glycerine 99.7% USP 93.45 grams Carbopol 980 NF (BF Goodrich) 2.00 grams Carbamide Peroxide (Degussa) USP 0.05 grams Distilled Water 3.00 grams Tris(hydroxymethyl)aminomethane USP 1.50 grams TOTAL 100 grams - The Carbopol 980 NF was dispersed under high shear in the Glycerine 99.7% USP and subsequently deaerated. The Carbamide Peroxide was then dissolved in this mixture under low shear mixing. The Tris(hydroxymethyl)aminomethane was dissolved in the Distilled Water, and this phase dispersed into the main phase under 28 @ Hg vacuum in order to avoid entrapment of air. The resulting gel was highly viscous and transparent.
- In the above composition, the tris(hydroxymethyl)aminomethane USP serves as both a neutralizer for thickening the acidic carboxypolymethylene (Carbopol 98O NF) and as an alkalizer to provide a suitable peroxidase-active pH during the use of this product. The pH of a 1:5 dilution (1 part Example V to 5 parts Distilled Water) is 5.4, and the dilution showed a hydrogen peroxide concentration of 969 micromoles per liter.
Claims (11)
1. An oral care composition for activating a peroxidase system in an animal oral cavity, comprising:
a non-aqueous or otherwise substantially water-free dentifrice;
a non-enzymatic, water-soluble, finely divided hydrogen per oxide precursor material incorporated within the dentifrice, the material capable of rapidly releasing an effective amount of hydrogen peroxide for activating the peroxidase system in the oral cavity upon contact with an aqueous solution, the material coated or encapsulated by being dispersed in a water insoluble, non-hygroscopic, viscous fluid or in a film-forming, melt-processable waxy solid, the fluid or solid selected from the group consisting of:
(a) liquid mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons and fluorosilicones, or (b) solid mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons, fluorosilicones, stearic acid, glycerin monosterate, paraffin wax, microcrystalline wax, and fatty alcohols, the fluid or solid being a non-solvent of the material; and
a pH-adjusting agent capable of producing a selected pH of between about 4.0 and about 6.5 in the aqueous solution.
2. A composition according to claim 1 , wherein the material is finely divided sodium percarbonate.
3. A composition according to claim 1 , wherein the material is finely divided carbamide peroxide.
4. A composition according to claim 1 , wherein the material is finely divided calcium peroxide.
5. A composition according to claim 1 , further comprising:
an abrasive.
6. A composition according to claim 1 , further comprising:
a flavorant.
7. A composition according to claim 1 , further comprising:
a thickener.
8. A composition according to claim 1 , further comprising:
an alkali metal thiocyanate.
9. A composition according to claim 8 , further comprising:
a peroxidase enzyme.
10. A process for manufacturing an oral care composition, comprising:
obtaining non-enzymatic, water-soluble, finely divided hydrogen peroxide precursor material,
providing a non-aqueous or otherwise substantially water-free dentifrice,
dispersing the finely divided hydrogen peroxide precursor material in a water insoluble, non-hygroscopic, viscous fluid or in a film-forming, melt-processable waxy solid, the fluid or solid selected from the group consisting of: (a) liquid mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons and fluorosilicones, or (b) solid mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons, fluorosilicones, stearic acid, glycerin monosterate, paraffin wax, microcrystalline wax, and fatty alcohols, the fluid or solid being a non-solvent of the finely divided hydrogen peroxide precursor material, so as to coat or encapsulate the finely divided hydrogen peroxide precursor material,
associating the finely divided hydrogen peroxide precursor material with a pH-adjusting agent capable of producing a selected pH of between about 4.0 and about 6.5 in an aqueous solution, and
incorporating the associated material within the dentifrice.
11. A method of activating a peroxidase system in an oral cavity of an animal, comprising:
selecting non-enzymatic, water-soluble, finely divided hydrogen peroxide precursor material capable of rapidly releasing an effective amount of hydrogen peroxide for activating the peroxidase system in the oral cavity upon contact with an aqueous solution, the material coated or encapsulated by being dispersed in a water insoluble, non-hygroscopic, viscous fluid or in a film-forming, melt-processable waxy solid, the fluid or solid selected from the group consisting of: (a) liquid mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons and fluorosilicones, or (b) solid mineral oils, vegetable oils, fatty esters, silicone fluids, fluorinated hydrocarbons, fluorosilicones, stearic acid, glycerin monosterate, paraffin wax, microcrystalline wax, and fatty alcohols, the fluid or solid being a non-solvent of the material,
mixing the material with a pH-adjusting agent capable of producing a selected pH of between about 4.0 and about 6.5 in the aqueous solution, and
administering to the oral cavity, the material and pH-adjusting agent incorporated within a non-aqueous or otherwise substantially water-free dentifrice.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/200,266 US20060182695A1 (en) | 1995-08-15 | 2005-08-09 | Peroxidase-activating oral compositions |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US236195P | 1995-08-15 | 1995-08-15 | |
US1253796P | 1996-02-29 | 1996-02-29 | |
US08/698,474 US5908614A (en) | 1995-08-15 | 1996-08-15 | Peroxidase-activating oral compositions |
US09/237,191 US6576227B1 (en) | 1995-08-15 | 1999-01-26 | Peroxidase-activating oral compositions |
US10/456,205 US20030211055A1 (en) | 1995-08-15 | 2003-06-06 | Peroxidase-activating oral compositions |
US11/200,266 US20060182695A1 (en) | 1995-08-15 | 2005-08-09 | Peroxidase-activating oral compositions |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/456,205 Continuation US20030211055A1 (en) | 1995-08-15 | 2003-06-06 | Peroxidase-activating oral compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060182695A1 true US20060182695A1 (en) | 2006-08-17 |
Family
ID=26670282
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/698,474 Expired - Lifetime US5908614A (en) | 1995-08-15 | 1996-08-15 | Peroxidase-activating oral compositions |
US09/237,191 Expired - Lifetime US6576227B1 (en) | 1995-08-15 | 1999-01-26 | Peroxidase-activating oral compositions |
US10/456,205 Abandoned US20030211055A1 (en) | 1995-08-15 | 2003-06-06 | Peroxidase-activating oral compositions |
US11/200,266 Abandoned US20060182695A1 (en) | 1995-08-15 | 2005-08-09 | Peroxidase-activating oral compositions |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/698,474 Expired - Lifetime US5908614A (en) | 1995-08-15 | 1996-08-15 | Peroxidase-activating oral compositions |
US09/237,191 Expired - Lifetime US6576227B1 (en) | 1995-08-15 | 1999-01-26 | Peroxidase-activating oral compositions |
US10/456,205 Abandoned US20030211055A1 (en) | 1995-08-15 | 2003-06-06 | Peroxidase-activating oral compositions |
Country Status (3)
Country | Link |
---|---|
US (4) | US5908614A (en) |
AU (1) | AU6725496A (en) |
WO (1) | WO1997007777A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100015068A1 (en) * | 2006-07-06 | 2010-01-21 | Massachusetts Institute Of Technology | Methods and Compositions For Altering Biological Surfaces |
US20160120793A1 (en) * | 2013-05-17 | 2016-05-05 | Alequident Limited | Oral Healthcare Product |
US10413500B2 (en) | 2016-12-20 | 2019-09-17 | Colgate-Palmolive Company | Oral care compositions and methods for whitening teeth |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5908614A (en) * | 1995-08-15 | 1999-06-01 | Montgomery; Robert Eric | Peroxidase-activating oral compositions |
ATE232715T1 (en) | 1995-09-25 | 2003-03-15 | Robert Eric Montgomery | TOOTH WHITENING COMPOSITIONS |
DE19710068A1 (en) * | 1997-03-12 | 1998-09-17 | Kramer Axel | Oral hygiene and oral health promoters |
US6221341B1 (en) * | 1997-11-19 | 2001-04-24 | Oraceutical Llc | Tooth whitening compositions |
CA2317067A1 (en) * | 1998-01-06 | 1999-07-15 | The Procter & Gamble Company | Antimicrobial peroxy acid oral care compositions and methods |
US20030198605A1 (en) * | 1998-02-13 | 2003-10-23 | Montgomery R. Eric | Light-activated tooth whitening composition and method of using same |
US6162055A (en) * | 1998-02-13 | 2000-12-19 | Britesmile, Inc. | Light activated tooth whitening composition and method of using same |
US6077502A (en) * | 1998-02-27 | 2000-06-20 | The Procter & Gamble Company | Oral care compositions comprising chlorite and methods |
US5972374A (en) * | 1998-04-02 | 1999-10-26 | Theisen; Thomas | Chewing gum with teeth whitener |
US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
US6365134B1 (en) | 1999-07-07 | 2002-04-02 | Scientific Pharmaceuticals, Inc. | Process and composition for high efficacy teeth whitening |
US7067115B2 (en) | 1999-07-07 | 2006-06-27 | Scientific Pharmaceuticals, Inc. | Process and composition for high efficacy teeth whitening |
ES2161631B1 (en) * | 1999-11-17 | 2002-06-01 | Univ Illes Balears | PRODUCT FOR DENTAL WHITENING. |
US6689344B2 (en) | 2000-03-17 | 2004-02-10 | Lg Household & Healthcare Ltd. | Patches for teeth whitening |
US8652446B2 (en) * | 2000-03-17 | 2014-02-18 | Lg Household & Healthcare Ltd. | Apparatus and method for whitening teeth |
BRPI0109371B1 (en) | 2000-03-17 | 2016-02-16 | Lg Household & Health Care Ltd | dry type dental bleaching plasters |
US7785572B2 (en) | 2000-03-17 | 2010-08-31 | Lg Household And Health Care Ltd. | Method and device for teeth whitening using a dry type adhesive |
AU2001261744A1 (en) * | 2000-05-19 | 2001-12-03 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
US6365133B1 (en) | 2000-08-02 | 2002-04-02 | James E. Rich | Dog chew toy containing edible pet toothpaste for dental care |
US6696043B2 (en) * | 2000-09-20 | 2004-02-24 | Scientific Pharmaceuticals, Inc. | Teeth whitening composition in the form of a chewing gum |
GB0100643D0 (en) * | 2001-01-10 | 2001-02-21 | Basf Ag | Liquid antimicrobial compositions |
US6946142B2 (en) * | 2001-06-23 | 2005-09-20 | Lg Household & Healthcare Ltd. | Multi-layer patches for teeth whitening |
US20050209654A1 (en) * | 2002-05-09 | 2005-09-22 | Boveja Birinder R | Method and system for providing adjunct (add-on) therapy for depression, anxiety and obsessive-compulsive disorders by providing electrical pulses to vagus nerve(s) |
AU2003240709B2 (en) * | 2002-05-29 | 2006-03-02 | Unilever Plc | Cosmetic compositions containing salts of malonic acid |
US20050147719A1 (en) * | 2003-02-10 | 2005-07-07 | Hill Ira D. | Impregnated, flexible, rawhide pet chews containing ingestible, therapeutic ingredients |
US20040156884A1 (en) * | 2003-02-10 | 2004-08-12 | Brown Dale G. | Emulsion impregnated rawhide chews with antimicrobially active chlorhexidine |
US20050064019A1 (en) * | 2003-02-10 | 2005-03-24 | Hill Ira D. | Impregnated, flexible, rawhide pet chews containing antimicrobially active chlorhexdine |
US7147888B2 (en) * | 2003-02-10 | 2006-12-12 | Whitehill Oral Technologies, Inc. | Emulsion impregnated rawhide chews |
US20060074450A1 (en) * | 2003-05-11 | 2006-04-06 | Boveja Birinder R | System for providing electrical pulses to nerve and/or muscle using an implanted stimulator |
US7444184B2 (en) * | 2003-05-11 | 2008-10-28 | Neuro And Cardial Technologies, Llc | Method and system for providing therapy for bulimia/eating disorders by providing electrical pulses to vagus nerve(s) |
US20050197678A1 (en) * | 2003-05-11 | 2005-09-08 | Boveja Birinder R. | Method and system for providing therapy for Alzheimer's disease and dementia by providing electrical pulses to vagus nerve(s) |
US20050036958A1 (en) * | 2003-08-13 | 2005-02-17 | Jianxun Feng | Dental bleaching |
US7601002B2 (en) * | 2004-03-29 | 2009-10-13 | Colgate-Palmolive Co | Dental whitening method |
US20060105025A1 (en) * | 2004-11-15 | 2006-05-18 | Hill Ira D | Recovery pet chews |
WO2008079101A2 (en) * | 2005-03-14 | 2008-07-03 | Custom Care Products, Inc. | Oral composition for improving mouth environment |
US20060248672A1 (en) * | 2005-05-06 | 2006-11-09 | Alex Dussaussoy | Lotion applicator |
US8137658B2 (en) * | 2005-06-28 | 2012-03-20 | Isp Investments Inc. | Tooth whitening compositions |
US20070071695A1 (en) | 2005-09-27 | 2007-03-29 | Colgate-Palmolive Company | Single phase whitening dentifrice |
CA2637266A1 (en) * | 2006-02-01 | 2007-08-09 | Premier Dental Products Company | Stable one-part aqueous tooth whitening composition |
EP1889600B1 (en) * | 2006-04-28 | 2012-07-25 | Ivoclar Vivadent AG | Method for teeth whitening |
US8642016B2 (en) * | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
US8905760B2 (en) * | 2008-11-04 | 2014-12-09 | Duane C. Keller | Methods and systems for progressively treating and controlling oral periopathogens causing systemic inflammations |
US8956161B2 (en) | 2008-11-04 | 2015-02-17 | Duane C Keller | Article and method for controlling oral-originated systemic disease |
US9642687B2 (en) | 2010-06-15 | 2017-05-09 | The Procter & Gamble Company | Methods for whitening teeth |
US8911712B2 (en) | 2010-10-04 | 2014-12-16 | Church & Dwight, Co., Inc. | Multi-purposed dentifrice |
US8591229B2 (en) | 2010-12-16 | 2013-11-26 | Duane C. Keller | Devices and methods for creating a positive pressure environment for treatment of oral biofilms associated with periodontal disease |
AU2012245338A1 (en) * | 2011-04-21 | 2013-10-24 | Intercontinental Great Brands Llc | Improved stability of peroxide in oral care compositions |
BR112014014118B1 (en) * | 2011-12-20 | 2018-05-02 | Colgate-Palmolive Company | Non-aqueous oral hygiene composition and method for teeth whitening comprising applying the composition |
CN104837530A (en) | 2012-12-14 | 2015-08-12 | 高露洁-棕榄公司 | Methods for whitening teeth |
GB201405874D0 (en) * | 2014-04-01 | 2014-05-14 | Aga Nanotech Ltd | A therapeutic agent for use in the treatment of infections |
RU2017104238A (en) | 2014-07-11 | 2018-08-13 | Конинклейке Филипс Н.В. | ORAL CARE COMPOSITION SYSTEM FOR AMORPHIC CALCIUM PHOSPHATE |
WO2016099875A1 (en) | 2014-12-15 | 2016-06-23 | 3M Innovative Properties Company | Methods and kits for removing calculus |
CN109414392B (en) | 2016-06-22 | 2022-07-08 | 3M创新有限公司 | Method and kit for removing calculus |
JP2019532965A (en) | 2016-10-20 | 2019-11-14 | スリーエム イノベイティブ プロパティズ カンパニー | Method and kit for removing tartar using non-enzymatic hydrogen peroxide decomposition catalyst |
ES2818999T3 (en) | 2017-11-03 | 2021-04-14 | Kyorin Ind Shenzhen Co Ltd | Chew toy for pets with oral care properties and toy preparation method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3065139A (en) * | 1953-11-12 | 1962-11-20 | Astra Ab | Anti-infectant topical preparations |
US4369173A (en) * | 1974-11-27 | 1983-01-18 | Wickhen Products, Inc. | Antiperspirant compositions |
US4891211A (en) * | 1988-06-29 | 1990-01-02 | Church & Dwight Co., Inc. | Stable hydrogen peroxide-releasing dentifice |
US4971782A (en) * | 1983-09-14 | 1990-11-20 | Peroxydent Group | Periodontal composition and method |
US5472685A (en) * | 1991-01-30 | 1995-12-05 | Colgate Palmolive Company | Antiplaque oral compositions |
US5908614A (en) * | 1995-08-15 | 1999-06-01 | Montgomery; Robert Eric | Peroxidase-activating oral compositions |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617430C3 (en) * | 1966-07-29 | 1980-07-10 | Wuerttembergische Parfuemerie-Fabrik Gmbh, 7332 Eislingen | Foaming, storage-stable toothpaste |
US4178362A (en) * | 1969-06-03 | 1979-12-11 | Telec S.A. | Enzymatic dentifrices |
US4150113A (en) * | 1969-06-03 | 1979-04-17 | Telec S.A. | Enzymatic dentifrices |
SE369036B (en) * | 1972-06-30 | 1974-08-05 | Astra Laekemedel Ab | |
FR2325364A1 (en) * | 1975-09-26 | 1977-04-22 | Goupil Jean Jacques | NEW TOOTHPASTE COMPOSITION |
FR2325363A1 (en) * | 1975-09-26 | 1977-04-22 | Goupil Jean Jacques | NEW COMPOSITION FOR ORAL USE |
GB1492660A (en) * | 1975-10-13 | 1977-11-23 | Colgate Palmolive Co | Dentifrices |
SE420793B (en) * | 1976-03-08 | 1981-11-02 | Astra Ewos Ab | FEEDING AGENT CONTAINING AN ANTI-BACTERIAL SYSTEM |
US4302116A (en) * | 1978-08-28 | 1981-11-24 | International Business Machines Corporation | Printing machine with throat for front loading of sheets |
GB2047091B (en) * | 1979-04-19 | 1983-05-18 | Muhlemann H R | Orally administrable compositions containing urea hydrogen peroxide |
US4269822A (en) * | 1979-07-20 | 1981-05-26 | Laclede Professional Products, Inc. | Antiseptic dentifrice |
FR2471222A1 (en) * | 1979-12-12 | 1981-06-19 | Interox | PROCESS FOR THE STABILIZATION OF PARTICLES CONTAINING PEROXYGENIC COMPOUNDS AND BLEACHING COMPOSITIONS CONTAINING PARTICLES STABILIZED ACCORDING TO THIS PROCESS |
US4578265A (en) * | 1981-08-13 | 1986-03-25 | Laclede Professional Products, Inc. | Di-enzymatic dentifrice |
US4564519A (en) * | 1983-06-06 | 1986-01-14 | Laclede Professional Products, Inc. | Di-enzymatic chewable dentifrice |
US4603045A (en) * | 1985-02-27 | 1986-07-29 | Smigel Irwin E | Toothpaste for bonded (composite filling material) as well as natural teeth |
US4837008A (en) * | 1985-04-09 | 1989-06-06 | Peroxydent Group | Periodontal composition and method |
US4897258A (en) * | 1987-01-12 | 1990-01-30 | Peroxydent Group | Periodontal composition and method |
EP0305365B1 (en) * | 1987-03-10 | 1993-08-04 | Peroxydent Group | Periodontal composition and method |
US4839157A (en) * | 1987-04-17 | 1989-06-13 | Colgate-Palmolive Company | Stable hydrogen peroxide dental gel containing fumed silicas |
US4788052A (en) * | 1987-04-17 | 1988-11-29 | Colgate-Palmolive Company | Stable hydrogen peroxide dental gel containing fumed silicas |
US4839156A (en) * | 1987-04-17 | 1989-06-13 | Colgate-Palmolive Company | Stable hydrogen peroxide dental gel |
US4980152A (en) * | 1987-08-06 | 1990-12-25 | Marion Laboratories | Oral preparation |
US5041280A (en) * | 1987-10-01 | 1991-08-20 | Epilady Usa, Inc. | Toothpaste composition for stain removal |
US4895721A (en) * | 1988-01-22 | 1990-01-23 | Carter-Wallace Inc. | Peroxide gel dentifrice compositions |
FR2627084B1 (en) * | 1988-02-11 | 1991-11-08 | Rcd Labo Sarl | SOLID GALENIC FORMS CONTAINING ONE OR MORE PEROXIDE SUBSTANCES RELEASING ACTIVE OXYGEN AND USED IN ORAL HYGIENE OR AS DECONTAMINANTS OF OPHTHALMIC LENSES |
US4925655A (en) * | 1988-03-04 | 1990-05-15 | Robell Research | Powder composition for forming a mouthwash |
US5370815A (en) * | 1988-09-06 | 1994-12-06 | Kessler; Jack H. | Viscous epidermal cleaner and disinfectant |
US5227161A (en) * | 1988-09-06 | 1993-07-13 | Symbollon Corporation | Method to clean and disinfect pathogens on the epidermis by applying a composition containing peroxidase, iodide compound and surfactant |
US5000941A (en) * | 1989-05-16 | 1991-03-19 | Milton P. Chernack | Dentifrice containing microencapsulated oxygen |
US4988500A (en) * | 1989-09-29 | 1991-01-29 | The Procter & Gamble Company | Oral compositions |
US5258132A (en) * | 1989-11-15 | 1993-11-02 | Lever Brothers Company, Division Of Conopco, Inc. | Wax-encapsulated particles |
US4976955A (en) * | 1989-11-20 | 1990-12-11 | Libin Barry M | Oral hygiene composition |
US5043176A (en) * | 1990-06-13 | 1991-08-27 | Haarmann & Reimer Corp. | Synergistic antimicrobial compositions |
US5888505A (en) * | 1991-02-21 | 1999-03-30 | Eoe, Inc. | Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system |
DE59208279D1 (en) * | 1991-09-03 | 1997-04-30 | Degussa | STORAGE-ENCLOSED ENCODED SODIUM CARBONATE AND METHOD FOR THE PRODUCTION THEREOF |
US5171564A (en) * | 1991-09-13 | 1992-12-15 | Colgate-Palmolive | Aqueous tooth whitening dentifrice |
US5256402A (en) * | 1991-09-13 | 1993-10-26 | Colgate-Palmolive Company | Abrasive tooth whitening dentifrice of improved stability |
AU660691B2 (en) * | 1991-09-13 | 1995-07-06 | Colgate-Palmolive Company, The | Abrasive tooth whitening dentifrice of improved stability |
US5250299A (en) * | 1991-09-23 | 1993-10-05 | Haarmann & Reimer Corp. | Synergistic antimicrobial compositions |
US5310563A (en) * | 1991-10-25 | 1994-05-10 | Colgate-Palmolive Company | Dental material and method for applying preventative and therapeutic agents |
US5279816A (en) * | 1991-11-22 | 1994-01-18 | Colgate-Palmolive Co. | Oral composition having improved tooth whitening effect |
US5262151A (en) * | 1991-11-25 | 1993-11-16 | Montgomery Robert E | Stabilized enzymatic antimicrobial compositions |
US5270033A (en) * | 1991-11-25 | 1993-12-14 | Montgomery Robert E | Antimicrobial composition and method of making same |
US5176899A (en) * | 1991-11-25 | 1993-01-05 | Montgomery Robert E | Antimicrobial dentifrice |
US5603924A (en) * | 1992-02-26 | 1997-02-18 | Opi Products, Inc. | Non-yellowing artificial fingernail composition |
US5310541A (en) * | 1992-08-27 | 1994-05-10 | Montgomery Robert E | Antimicrobial rawhide animal chew containing an oxidoreductase and oxidoreductase substrate |
US5264205A (en) * | 1992-09-09 | 1993-11-23 | Faria Ltd. | Oral hygiene composition |
CA2081408C (en) * | 1992-10-26 | 2003-05-06 | Serguei V. Khartchenko | Composition for the cleaning of teeth and the prophylaxis of caries |
US5302375A (en) * | 1992-11-19 | 1994-04-12 | Colgate-Palmolive Company | Oral composition having improved tooth whitening effect |
US5405836A (en) * | 1993-03-02 | 1995-04-11 | Nabisco, Inc. | Pet foods with water-soluble zinc compound coating for controlling malodorous breath |
US5302374A (en) * | 1993-04-21 | 1994-04-12 | Dental Concepts Inc. | Oral hygiene system |
US5496542A (en) * | 1993-10-25 | 1996-03-05 | Church & Dwight Co., Inc. | Stable sodium percarbonate formulation |
US5374368A (en) * | 1993-10-25 | 1994-12-20 | Church & Dwight Co., Inc. | Stable sodium percarbonate formulation |
US5424060A (en) * | 1993-10-25 | 1995-06-13 | Church & Dwight Co., Inc. | Dentifrice composition containing stabilized sodium percarbonate |
US5403578A (en) * | 1994-02-08 | 1995-04-04 | Gordon; Norman | Stable tooth and gum dentifrice with microencapsulation and method for making same |
US5460743A (en) * | 1994-05-09 | 1995-10-24 | Lever Brothers Company, Division Of Conopco, Inc. | Liquid cleaning composition containing polyvinyl ether encapsulated particles |
GB2290234B (en) * | 1994-06-07 | 1998-06-10 | Janina International | Oral care products |
US5632972A (en) * | 1994-06-30 | 1997-05-27 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Method for treating gingival and periodontal tissues |
US5500207A (en) * | 1994-11-18 | 1996-03-19 | Goulet; Marie-Kateri | Method of whitening teeth and composition therefore |
US5618518A (en) * | 1995-06-06 | 1997-04-08 | Indiana University Foundation | Methods and compositions for use against dental calculus in domestic animals |
WO1997006696A1 (en) * | 1995-08-15 | 1997-02-27 | Robert Eric Montgomery | Improved proteinaceous animal chew with dentally therapeutic cation |
ATE232715T1 (en) * | 1995-09-25 | 2003-03-15 | Robert Eric Montgomery | TOOTH WHITENING COMPOSITIONS |
US5816802A (en) * | 1995-09-25 | 1998-10-06 | R. Eric Montgomery | Flexible dental tray |
US5693334A (en) * | 1995-10-05 | 1997-12-02 | Church & Dwight Co., Inc. | Chewing gum product with dental health benefits |
US5741525A (en) * | 1995-10-24 | 1998-04-21 | Marshall University Research Corporation | Vaginal pharmaceutical hydrogen peroxide composition |
US5631000A (en) * | 1996-03-11 | 1997-05-20 | Laclede Professional Products, Inc. | Anhydrous tooth whitening gel |
EP0917455A1 (en) * | 1996-07-29 | 1999-05-26 | Robert Eric Montgomery | Chlorine dioxide tooth whitening compositions |
US6475469B1 (en) * | 1996-11-21 | 2002-11-05 | Applied Dental Sciences, Inc. | Compositions for removing tooth stains |
US6221341B1 (en) * | 1997-11-19 | 2001-04-24 | Oraceutical Llc | Tooth whitening compositions |
US6348518B1 (en) * | 1997-12-10 | 2002-02-19 | R. Eric Montgomery | Compositions for making an artificial prosthesis |
US6162055A (en) * | 1998-02-13 | 2000-12-19 | Britesmile, Inc. | Light activated tooth whitening composition and method of using same |
JP2002503520A (en) * | 1998-02-19 | 2002-02-05 | オラシューティカル エルエルシー | Antibacterial denture adhesive composition |
-
1996
- 1996-08-15 US US08/698,474 patent/US5908614A/en not_active Expired - Lifetime
- 1996-08-15 WO PCT/US1996/013240 patent/WO1997007777A1/en active Application Filing
- 1996-08-15 AU AU67254/96A patent/AU6725496A/en not_active Abandoned
-
1999
- 1999-01-26 US US09/237,191 patent/US6576227B1/en not_active Expired - Lifetime
-
2003
- 2003-06-06 US US10/456,205 patent/US20030211055A1/en not_active Abandoned
-
2005
- 2005-08-09 US US11/200,266 patent/US20060182695A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3065139A (en) * | 1953-11-12 | 1962-11-20 | Astra Ab | Anti-infectant topical preparations |
US4369173A (en) * | 1974-11-27 | 1983-01-18 | Wickhen Products, Inc. | Antiperspirant compositions |
US4971782A (en) * | 1983-09-14 | 1990-11-20 | Peroxydent Group | Periodontal composition and method |
US4891211A (en) * | 1988-06-29 | 1990-01-02 | Church & Dwight Co., Inc. | Stable hydrogen peroxide-releasing dentifice |
US5472685A (en) * | 1991-01-30 | 1995-12-05 | Colgate Palmolive Company | Antiplaque oral compositions |
US5908614A (en) * | 1995-08-15 | 1999-06-01 | Montgomery; Robert Eric | Peroxidase-activating oral compositions |
US6576227B1 (en) * | 1995-08-15 | 2003-06-10 | Oraceutical Innovative Properties, Llc | Peroxidase-activating oral compositions |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100015068A1 (en) * | 2006-07-06 | 2010-01-21 | Massachusetts Institute Of Technology | Methods and Compositions For Altering Biological Surfaces |
US20160120793A1 (en) * | 2013-05-17 | 2016-05-05 | Alequident Limited | Oral Healthcare Product |
US10413500B2 (en) | 2016-12-20 | 2019-09-17 | Colgate-Palmolive Company | Oral care compositions and methods for whitening teeth |
US11033476B2 (en) | 2016-12-20 | 2021-06-15 | Colgate-Palmolive Company | Oral care compositions and methods for whitening teeth |
Also Published As
Publication number | Publication date |
---|---|
US6576227B1 (en) | 2003-06-10 |
WO1997007777A1 (en) | 1997-03-06 |
US20030211055A1 (en) | 2003-11-13 |
US5908614A (en) | 1999-06-01 |
AU6725496A (en) | 1997-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6576227B1 (en) | Peroxidase-activating oral compositions | |
US4537764A (en) | Stabilized enzymatic dentifrice containing B-D-glucose and glucose oxidase | |
CA2124336C (en) | Antimicrobial dentifrice | |
KR910002667B1 (en) | Di-enzymatic dentifrice | |
US4269822A (en) | Antiseptic dentifrice | |
EP0957806B1 (en) | COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (E h) LEVELS | |
BE1001110A5 (en) | Composition use oral including polyphosphate and antibacterial agent and method of use for inhibiting scale plate and dental. | |
US4152418A (en) | Zinc and enzyme mouthwash and mouthwash concentrate for reducing dental plaque and calculus formation | |
US6322773B1 (en) | Tooth-bleaching compositions | |
EP0746303B1 (en) | Stabilized enzymatic antimicrobial compositions | |
CA2143111A1 (en) | Stabilized chewable antimicrobial animal foodstuff | |
JPH01501000A (en) | Enzyme-containing disinfectant composition and dental and wound care products containing this composition | |
RU2300366C2 (en) | Enzyme-containing bicomponent composition against dental deposit | |
US5270033A (en) | Antimicrobial composition and method of making same | |
US20070081952A1 (en) | Composition for the treatment of bad breath | |
FI87423C (en) | TANDVAORDSPRODUKT | |
US4559223A (en) | Silver sulfadiazine and/or zinc sulfadiazine-containing toothpaste or oral medicament | |
FR2462424A1 (en) | COMPOSITION BASED ON BENZYL PEROXIDE, IN PARTICULAR FOR THE TREATMENT OF ACNE | |
JPH09295924A (en) | Acid neutralizing agent for dental plaque and composition for oral cavity | |
CN110151574A (en) | A kind of stability chlorine dioxide gargle and preparation method thereof | |
EP1314419B1 (en) | Tooth bleaching compositions | |
JP2002020292A (en) | Composition containing ascorbic acid phosphoric esters | |
US20070202056A1 (en) | Oral composition for improving mouth environment | |
JPH0425924B2 (en) | ||
US20090155188A1 (en) | mouth environment with oral composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BRITESMILE PROFESSIONAL, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRITESMILE PROFESSIONAL, INC.;REEL/FRAME:020492/0570 Effective date: 20080211 |
|
AS | Assignment |
Owner name: DISCUS DENTAL, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRITESMILE PROFESSIONAL, LLC;REEL/FRAME:022029/0414 Effective date: 20081219 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |